A new study reveals that adults diagnosed with type 1 diabetes face a heightened risk of cardiovascular disease and death, with no better prognosis than those diagnosed in childhood.
Naoko Tanese from New York University School of Medicine outlines their work around Huntington’s disease (HD) and new targets for therapeutic intervention
Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University provides an overview of the professional development courses offered at the unit
Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers.
Life Science leaders from across the UK have welcomed a new agreement that will make it easier for life-changing clinical trials and medicines research and development to take place across different parts of the UK
Islam Elkonaissi and Zahra Laftah from the UKCPA explore the British model of supporting excellence in clinical pharmacy practice
In the UK, evidence that pharmacists...
Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression
Cancer progression, meaning the evolution of localised...
